Luye Pharma Group Ltd (LUP) — Cash Flow-to-Debt Ratio
Luye Pharma Group Ltd (LUP) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €344.86 Million could theoretically repay 0% of its total liabilities (€14.11 Billion) in one year. See LUP financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Luye Pharma Group Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Luye Pharma Group Ltd across 10 annual periods. For the full cash flow conversion analysis, see Luye Pharma Group Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Luye Pharma Group Ltd (2016–2025)
Year-by-year debt coverage analysis for Luye Pharma Group Ltd. Check LUP cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | €1.78 Billion | €14.47 Billion | ▲ +918.2% |
| 2024 | 0.01x | €167.76 Million | €13.86 Billion | ▼ -90.9% |
| 2023 | 0.13x | €1.60 Billion | €11.96 Billion | ▲ +6.5% |
| 2022 | 0.13x | €1.65 Billion | €13.21 Billion | ▲ +824.7% |
| 2021 | 0.01x | €182.37 Million | €13.47 Billion | ▼ -83.6% |
| 2020 | 0.08x | €1.03 Billion | €12.53 Billion | ▼ -42.4% |
| 2019 | 0.14x | €1.42 Billion | €9.94 Billion | ▲ +31.4% |
| 2018 | 0.11x | €1.05 Billion | €9.60 Billion | ▼ -56.4% |
| 2017 | 0.25x | €964.10 Million | €3.86 Billion | ▲ +11.4% |
| 2016 | 0.22x | €592.03 Million | €2.64 Billion | — |